Boston Private Bank & Trust’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Boston Private Bank & Trust’s Portfolio CELGZ Stock Details CELGZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$13K	Hold	4,220	–	–	﹤0.01%	791
2014 Q4	$13K	Hold	4,220	–	–	﹤0.01%	822
2014 Q3	$14K	Hold	4,220	–	–	﹤0.01%	828
2014 Q2	$11K	Hold	4,220	–	–	﹤0.01%	816
2014 Q1	$12K	Hold	4,220	–	–	﹤0.01%	834
2013 Q4	$12K	Buy	4,220 +3,220	+322%	+$9.04K	﹤0.01%	828
2013 Q3	$8K	Hold	1,000	–	–	﹤0.01%	843
2013 Q2	$7K	Buy	+1,000	New	+$7.25K	﹤0.01%	829

Other funds holding CELGZ

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Boston Private Bank & Trust's CELGZ Position: Q1 2015 in Review

Boston Private Bank & Trust held its Celgene Corporation Contingent Value Rights (CELGZ) position steady in Q1 2015 at 4,220 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #791.

Boston Private Bank & Trust first reported a position in CELGZ in Q2 2013 and has held it in 8 quarters since. The position peaked at $14K in Q3 2014. 22 funds tracked by Wall St. Rank hold CELGZ as of Q1 2015.

Boston Private Bank & Trust held 4,220 shares of Celgene Corporation Contingent Value Rights worth $13K as of Q1 2015.
Boston Private Bank & Trust left its Celgene Corporation Contingent Value Rights share count unchanged in Q1 2015.
Celgene Corporation Contingent Value Rights made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #791 holding.
Boston Private Bank & Trust first reported a position in Celgene Corporation Contingent Value Rights in Q2 2013 and has held it in 8 quarters since.
Boston Private Bank & Trust's Celgene Corporation Contingent Value Rights position peaked at $14K in Q3 2014.
22 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.